Computer systems for the prediction of xenobiotic metabolism

SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules

Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436

Drug Metabolism: Chemical and Biochemical Aspects

Testa, B., & Jenner, P. G. (1976) · Medical Entomology and Zoology · Cited by 308

Knowledge-Based Expert Systems for Toxicity and Metabolism Prediction: DEREK, StAR and METEOR

Greene, N., Judson, P. N., Langowski, J. J., & Marchant, C. A. (1999) · SAR and QSAR in environmental research · doi:10.1080/10629369908039182 · Cited by 251

QSAR in Environmental Toxicology - II

(1987) · Springer eBooks · doi:10.1007/978-94-009-3937-0 · Cited by 248

Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.

Ekins, S., de Groot, M. J., & Jones, J. P. (2001) · PubMed · Cited by 202

META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals

Klopman, G., Dimayuga, M., & Talafous, J. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00022a014 · Cited by 170

Properties of cytochrome P450 isoenzymes and their substrates part 2: properties of cytochrome P450 substrates

Smith, D. A., Ackland, M. J., & Jones, B. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01085-4 · Cited by 121

META. 2. A Dictionary Model of Mammalian Xenobiotic Metabolism

Talafous, J., Sayre, L. M., Mieyal, J. J., & Klopman, G. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00022a015 · Cited by 99

Properties of cytochrome P450 isoenzymes and their substrates Part 1: active site characteristics

Smith, D. A., Ackland, M. J., & Jones, B. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01081-7 · Cited by 91

Quantitative Structure-Activity Relationships of Cytochrome P-450

Hansch, C. H., & Zhang, L. (1993) · Drug Metabolism Reviews · doi:10.3109/03602539308993972 · Cited by 75

Applied Pharmacokinetics in Drug Development

Caldwell, G. W., Yan, Z., Masucci, J. A., Hageman, W., Leo, G. C., & Ritchie, D. M. (2003) · Pharmaceutical Development and Regulation · doi:10.1007/bf03257371 · Cited by 7

The ECVAM Workshops: A Critical Assessment of their Impact on the Development, Validation and Acceptance of Alternative Methods

Combes, R. D. (2002) · Alternatives to Laboratory Animals · doi:10.1177/026119290203002s25 · Cited by 7

Study of the Reactivity of (100) Felodipine Surface Model Based on DFT Concepts

Tepech-Carrillo, C., Licona-Ibarra, R., Rivas-Silva, J. F., & Flores-Riveros, A. (2019) · Open Journal of Physical Chemistry · doi:10.4236/ojpc.2019.91001 · Cited by 6

Comprehensive Expert Systems to Predict Drug Metabolism

Hawkins, D. R. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00150-4 · Cited by 6

Equation chapter 1 section 1A new method for predicting human hepatic clearance fromin Vitro experimental data using molecular descriptors

Lee, S., & Kim, D. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02977693 · Cited by 6

Cytochrome P450 enzymes— in vitro , in vivo , and in silico studies

Turpeinen, M. (2006) · Cited by 6

Evaluation of Violacein Metabolic Stability and Metabolite Identification in Human, Mouse, and Rat Liver Microsomes

Calemi, D. B. D. A., Godoi, A. B., Minuti, G., Neto, F. C., Hispagnol, G. F., Pilon, A. C., Costa, J. L., Hyslop, S., & Antunes, N. D. J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050601 · Cited by 5

QSAR Analysis for the Inhibition of the Mutagenic Activity by Anthocyanin Derivatives

Szewczuk, N. A., Duchowicz, P. R., & Pomilio, A. B. (2020) · International Journal of Quantitative Structure-Property Relationships · doi:10.4018/ijqspr.20201001.oa1 · Cited by 5

Recent Development and Application of Virtual Screening in Drug Discovery: An Overview

Hou, T., & Xu, X. (2010) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805206610603010675 · Cited by 5

Efficient and Effective Drug Development

Colburn, W. A., & Heath, G. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9216-1_1 · Cited by 4

State-of-the-Art and Dissemination of Computational Tools for Drug-Design Purposes: A Survey Among Italian Academics and Industrial Institutions

Artese, A., Alcaro, S., Moraca, F., Reina, R., Ventura, M., Costantino, G., Beccari, A. R., & Ortuso, F. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.59 · Cited by 4

Nontargeted screening of veterinary drugs and their metabolites in milk based on mass defect filtering using liquid chromatography–high‐resolution mass spectrometry

Chen, T., Liang, W., Zhang, X., Lu, X., Zhao, C., & Xu, G. (2021) · Electrophoresis · doi:10.1002/elps.202100296 · Cited by 4

Drug Metabolism In Preclinical Development

Sinz, M. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9216-1_4 · Cited by 4

Evaluation of descriptors and classification schemes to predict cytochrome substrates in terms of chemical information

Block, J. H., & Henry, D. R. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9176-9 · Cited by 4

MetaQM: Exploring the Role of QM Calculations in Drug Metabolism Prediction

Macorano, A., Vittorio, S., Mazzolari, A., Pedretti, A., & Vistoli, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412087 · Cited by 3

TRANSFER LEARNING FOR CYTOCHROME P450 ISOZYME SELECTIVITY PREDICTION

Teramoto, R., & Kato, T. (2011) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720011005434 · Cited by 3

Untargeted metabolomics analysis assisted by signal selection for comprehensively identifying metabolites of new psychoactive substances: 4-MeO-α-PVP as an example

Wu, H., Chen, Y.-C., Hsu, J., Lu, H.-T., Pan, Y., Ma, M.-C., & Liao, P. (2023) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3447 · Cited by 3

Life Science Applications of Fukui Functions

Beck, M. E., & Schindler, M. (2007) · Wiley eBooks · doi:10.1002/9783527611249.ch24 · Cited by 3

Molecular Modeling in Drug Design

Marshall, G. R., & Beusen, D. D. (2003) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc003 · Cited by 3

Modeling and Informatics in Drug Design

Bharatam, P. V., Khanna, S., & Francis, S. M. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse031 · Cited by 3

Computational approaches for drug-metabolizing enzymes: Concepts and challenges

Ashfaq, U. A., Shahid, F., & Munir, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95120-3.00001-4 · Cited by 2

Virtual Screening and Its Applications in Drug Discovery Process

Mariappan, G., & Kumari, A. (2018) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-7326-5.ch005 · Cited by 2

Calculation of the bioaccessibility of drugs using data on the similarity of their molecular structures

Raevsky, O. A., Казаченко, И. В., & Raevskaya, O. E. (2004) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-005-0001-7 · Cited by 2

Chemoinformatics on Metabolic Pathways

Hattori, M., & Kotera, M. (2013) · IGI Global eBooks · doi:10.4018/978-1-4666-3604-0.ch053 · Cited by 1

QSAR and Molecular Modeling Approaches for Prediction of Drug Metabolism

Braga, R. C., Alves, V. M., Silva, F. C., & Andrade, C. H. (2015) · Wiley eBooks · doi:10.1002/9780470921920.edm139 · Cited by 1

Application of Data Mining Algorithms in Pharmaceutical Research and Development

Balakin, K. V., & Savchuk, N. (2009) · Wiley eBooks · doi:10.1002/9780470567623.ch3

Drug Bioavailability, Distribution and Clearance Prediction

Bains, W. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200300066

Utility of Structural Information to Predict Drug Clearance from in Vitro Data

Lee, S., & Kim, D. (2010) · Interdisciplinary Bio Central · doi:10.4051/ibc.2010.2.2.0003

Structure-activity studies of novel noncamptothecin topoisomerase I-targeting agents

Feng, W. (2008) · doi:10.7282/t3wd40tk

Carcinogen Specific Expression Profiling: Prediction of Carcinogenic Potential?

Forschungsgemeinschaft, D. (2010) · Wiley eBooks · doi:10.1002/9783527634705.ch3b

Soft Drugs

Bodor, N. S., & Buchwald, P. (2012) · Wiley eBooks · doi:10.1002/9781118407738.ch5

Possibilities of using information resources In bioremediation

Babynin, E. V., & Degtyareva, I. A. (2021) · Proceedings of universities Applied chemistry and biotechnology · doi:10.21285/2227-2925-2021-11-3-372-383

Principles of Drug Metabolism

Dalvie, D., & Testa, B. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc033.pub3

Chemoinformatics on Metabolic Pathways

Hattori, M., & Kotera, M. (2010) · IGI Global eBooks · doi:10.4018/978-1-61520-911-8.ch017

Metabolism Prediction: Identification of Potential Sites of Metabolism in Lead Molecules

Wunnava, A. U., Mak, K., Zhang, S., Pang, J.-C., & Pichika, M. R. (2025) · Springer eBooks · doi:10.1007/978-981-96-4154-3_17

In Vitro Toxicology for Cosmetics

Boughton, R. M. (2007) · Elsevier eBooks · doi:10.1016/b978-081551567-8.50011-5

Synthetic Cannabinoids (K2, Spices) Where Drug Test Could Be Negative in a Drug Abuser

Yan, J., Walker, E., & Fu, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-15015-8_16

BindingDB Entry 50043031: Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2.

BindingDB (2014) · UC San Diego · doi:10.7270/q2cv4k40

BindingDB Entry 50007105: Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target.

BindingDB (2021) · UC San Diego · doi:10.7270/q2f76gvb

Development of in silico models for the prediction of toxicity incorporating ADME information

Piechota, P. (2016) · Liverpool John Moores University · doi:10.24377/ljmu.t.00004554 · Cited by 4

ADMET in silico modelling: towards prediction paradise?

Waterbeemd, H. V. D., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,924

Computational prediction of human drug metabolism

Ekins, S., Andreyev, S., Ryabov, A., Kirillov, E., Rakhmatulin, E. A., Bugrim, A. E., & Nikolskaya, T. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.2.303 · Cited by 87

Computer-Assisted Methods in Chemical Toxicity Prediction

Mohan, C. G., Gandhi, T., Garg, D., & Shinde, R. N. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707780619554 · Cited by 74

In Silico Toxicokinetics

Chakraborty, S., Boyina, H. K., Mitta, R., & Nayaka, R. (2026) · CRC Press eBooks · doi:10.1201/9781003666844-10